DistantNews
Support us
๐Ÿ‡ฒ๐Ÿ‡ฆ Morocco /Health & Science

Doctor warns against excessive garlic consumption to treat atherosclerosis

From Tรฉlรฉgraphe · () Arabic

Translated from Arabic and summarized by DistantNews. Read the original for the full story.

At a glance

Newswire From a news agency Context piece
  • Vascular specialist Alexander Shishonin says garlic may have vascular-protective and anti-inflammatory properties but cannot eliminate atherosclerotic plaques.
  • He warns against consuming excessive garlic in search of a therapeutic effect.
  • Shishonin recommends addressing the causes of atherosclerosis through diet, physical activity and a broader treatment approach.

Garlic can be part of a healthy diet, but it cannot remove the plaques that cause atherosclerosis, according to vascular specialist Alexander Shishonin.

Shishonin said garlic contains a biologically active substance with vascular-protective, anti-inflammatory and antibacterial properties. Eating it may benefit the lining of blood vessels and support intestinal function.

He warned against consuming excessive amounts of garlic in the hope of achieving a clear treatment effect. Once atherosclerotic plaques have formed, garlic alone cannot eliminate them. People with atherosclerosis should identify the causes of the changes and the factors that are allowing the disease process to continue.

The specialist also stressed the importance of diet and physical activity as part of a comprehensive treatment approach. Atherosclerotic plaques are cholesterol deposits on the inner lining of arteries, and their accumulation is associated with the development of atherosclerosis.

Garlic is a useful food product, but it is not a treatment for atherosclerosis.

· Alexander ShishoninThe vascular specialist distinguishes garlicโ€™s dietary benefits from medical treatment.
About this summary

Originally published by Tรฉlรฉgraphe in Arabic. Translated, summarized, and contextualized automatically by DistantNews, with a note on how the source frames the story. Not individually reviewed before publishing. How this works.